Ruili Medical Beauty (02135.HK) issued a profit warning, expecting the mid-term attributable loss to shareholders to increase by approximately 8 million yuan year on year.

Intelligence Finance APP News, Rilai Medical Beauty (02135.HK) issued an announcement, the board of directors expects the group to achieve: revenue of approximately RMB 85 million for the six months ended June 30, 2025 (revenue of approximately RMB 117 million for the six months ended June 30, 2024); and a loss of approximately RMB 8 million for the six months ended June 30, 2025 for the controlling shareholders of the parent company (a loss of approximately RMB 2 million for the six months ended June 30, 2024 for the controlling shareholders of the parent company).